US Single-Use Bioreactors Market (2026-2031)
The US Single-Use Bioreactors Market was valued at $872.3 Million in 2026 and projected to reach to $1522.8 Million by 2031, representing a compound annual growth rate of 11.8%. The US single-use bioreactors market is poised for significant expansion through 2031, driven by the biopharmaceutical industry's shift toward flexible, scalable manufacturing solutions.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
US Single-Use Bioreactors Market Trends and Insights
- The US market benefits from robust biopharmaceutical manufacturing infrastructure, increasing adoption of single-use technologies by contract manufacturers, and rising demand for flexible, cost-effective production solutions.
- In 2026, the US represents a mature yet rapidly evolving segment within the global single-use bioreactors landscape, driven by regulatory support and technological innovation. By 2031, the US market is expected to capture significant value as biopharmaceutical companies and CDMOs scale production capacity and transition from traditional stainless-steel systems.
- The US growth trajectory is supported by accelerating cell and gene therapy development, increased outsourcing to contract manufacturers, and the need for rapid manufacturing scale-up.
- Single-use bioreactors in the US enable faster time-to-market, reduced capital expenditure, and simplified facility operations, making them increasingly attractive to both established and emerging biotech firms..
Key Market Statistics
- CAGR (2026-2031) 11.8% CAGR
- Market Size, 2026 ~USD 872.3 Million
- Forecast, 2031 ~USD 1522.8 Million
- Country US
US Single-Use Bioreactors Market Overview
Market Valuation Growth :
The US single-use bioreactors market is valued at $872.3 million in 2026 and is projected to reach $1,522.8 million by 2031, representing a robust 11.8% CAGR over the forecast period.
Advanced Manufacturing Infrastructure :
The US benefits from a well-established biopharmaceutical manufacturing ecosystem with leading contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) increasingly adopting single-use bioreactor technologies.
Cost-Effectiveness Adoption :
US manufacturers are rapidly transitioning to single-use bioreactors due to reduced capital expenditure, lower operational costs, and decreased cleaning validation requirements compared to traditional stainless steel systems.
Regulatory Support & Innovation :
The FDA's supportive stance on single-use technologies and continuous innovation in bioreactor design by US-based companies are driving market expansion and accelerating adoption across therapeutic areas.
US Single-Use Bioreactors Market Dynamics
- Contract manufacturers and CDMOs are leading adoption, leveraging single-use systems to reduce time-to-market and operational risks.
- The market's 11.8% CAGR reflects growing demand for personalized medicine, cell and gene therapy production, and vaccine manufacturing capabilities. Key growth catalysts include increasing biosimilar development, rising investment in cell therapy manufacturing, and the need for rapid production capacity scaling.
- US-based pharmaceutical companies are prioritizing supply chain resilience and manufacturing agility, making single-use bioreactors an attractive alternative to traditional infrastructure.
- Technological advancements in sensor integration and automation will further enhance market penetration across small, medium, and large-scale production facilities..
Market Ecosystem
SINGLE-USE BIOREACTORS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Deployed six 4,000 L ABEC CSR single-use bioreactors at its Pune facility to support large-scale manufacturing of Novavax’s NVX-CoV2373 vaccine. | Established 24,000 L of single-use production capacity | The 4,000 L systems doubled productivity per unit of floor space, supported accelerated facility startup, and reduced manufacturing cost per dose. |
 |
Implemented Cytiva Xcellerex Disposable Reactors (XDR) for mAb and bispecific antibody production. | Demonstrated that XDR bioreactors can be used effectively for antibody production | The system met all benchmarks for viable cell density, viability, integral viable cell count (IVC), and titer | The real-time CO2 monitoring proved effective, allowing maintenance of optimal culture conditions. |
 |
Implemented Sartorius Ambr and BIOSTAT STR platforms, ranging from process-development systems to 500 L and 2,000 L single-use bioreactors, at its San Diego biologics facility. | Enabled consistent scale-up from development to GMP production, improved process-data continuity, and supported seamless technology transfer for Phase I through commercial biologics manufacturing. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- The US single-use bioreactors market is valued at $872.3 million in 2026 and will reach $1,522.8 million by 2031, growing at 11.8% CAGR.
- The US market is driven by strong biopharmaceutical manufacturing demand, CDMO expansion, and adoption of flexible production technologies.
- Cell and gene therapy development in the US is accelerating single-use bioreactor adoption for rapid, scalable manufacturing.
- The US market benefits from regulatory support, technological innovation, and the shift away from capital-intensive stainless-steel systems.
Single-Use Bioreactors Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | CELL & GENE THERAPY (Molecule Type) |
| Forecast Period | 2026-2031 |
| Growth Rate | CAGR of 12% from 2026 to 2031 |
| Largest Segment | BIOPRODUCTION (Application) |
| Market Size Base Year (Billions) | ~USD 5.44 (2026) |
| Revenue Forecast (Billions) | ~USD 9.58 (2031) |
| Segments Covered | Product, Scale Range, Type, Molecule Type, Cell Type, Application, Process Mode, End User |
US Single-Use Bioreactors Market Report Segmentation
8 segment dimensions are covered across the global market.
By Product
- Other Products
- Single-Use Assemblies
- Single-Use Bags
- Single-Use Bioreactor Systems
By Scale Range
- 101-500 L Bioreactors
- 11-100 L Bioreactors
- 501-1,500 L Bioreactors
- >1,500 L Bioreactors
- <=10 L Bioreactors
By Type
- 101-500 L Bioreactors
- 11-100 L Bioreactors
- 2D Single-Use Bags
- 3D Single-Use Bags
- 501-1,500 L Bioreactors
- >1,500 L Bioreactors
- Bubble-Column Single-Use Bioreactors
- Fixed-Bed Single-Use Bioreactors
- Other Single-Use Bioreactors
- Stirred-Tank Single-Use Bioreactors
- Wave-Induced Single-Use Bioreactors
- <=10 L Bioreactors
By Molecule Type
- Cell & Gene Therapy
- Monoclonal Antibodies
- Therapeutic Proteins & Peptides
- Vaccines
By Cell Type
- Bacterial Cells
- Mammalian Cells
- Other Cells
- Yeast Cells
By Application
- Bioproduction
- Process Development
- Research & Development
By Process Mode
- Batch Process Mode
- Feb-Batch Process Mode
- Fed-Batch Process Mode
- Perfusion/Continuous Process Mode
By End User
- Academic & Research Institutes
- Cros & Cmos
- Pharmaceutical & Biotechnology Companies
Target Audience
- Bioreactor Manufacturers & Suppliers : Need US market data to benchmark performance, identify growth opportunities, optimize product portfolios, and develop targeted go-to-market strategies for single-use bioreactor systems.
- Contract Manufacturers & CDMOs : Require market insights to evaluate single-use technology investments, assess competitive positioning, plan capacity expansion, and justify capital expenditure for manufacturing infrastructure upgrades.
- Biopharmaceutical Companies : Seek market intelligence to inform manufacturing strategy decisions, evaluate outsourcing partnerships, assess supply chain resilience, and plan production scaling for pipeline programs.
- Private Equity & Investment Firms : Need validated US market data and growth forecasts to evaluate investment opportunities, assess portfolio company performance, and identify acquisition targets in the bioreactor and bioprocessing sectors.
- Regulatory & Consulting Firms : Require comprehensive US market analysis to advise clients on regulatory compliance, manufacturing best practices, technology adoption strategies, and competitive landscape positioning.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise US market valuation ($872.3M in 2026) and verified forecast data ($1,522.8M by 2031) to support investment decisions, business planning, and competitive positioning in the single-use bioreactor sector.
- Regional Competitive Intelligence : Gain insights into US-specific market dynamics, key players, adoption rates among CMOs/CDMOs, and regional regulatory factors that differentiate the US market from global competitors.
- Strategic Expansion Planning : Identify high-growth segments within the US market, including cell therapy, gene therapy, and vaccine production, to prioritize product development, partnerships, and geographic expansion strategies.
- Investment & Funding Decisions : Access credible market data and growth projections to justify capital allocation, secure investor confidence, and evaluate acquisition or partnership opportunities in the US bioreactor manufacturing space.
- Technology & Product Development : Understand US customer requirements, manufacturing trends, and emerging needs to guide R&D initiatives, product innovation, and feature development aligned with market demand.
Frequently asked questions
What is the current size of the US single-use bioreactors market?
The US single-use bioreactors market is valued at $872.3 million in 2026 and is expected to grow to $1,522.8 million by 2031.
What is the growth rate of the US single-use bioreactors market?
The US single-use bioreactors market is projected to grow at a compound annual growth rate (CAGR) of 11.8% from 2026 to 2031.
What are the primary drivers of growth in the US single-use bioreactors market?
Key drivers include increased biopharmaceutical manufacturing demand, CDMO expansion, cell and gene therapy development, regulatory support, and the shift from stainless-steel to single-use systems.
Which segments are driving the US single-use bioreactors market?
The US market is driven by contract manufacturers, biopharmaceutical companies, cell and gene therapy developers, and organizations seeking cost-effective, flexible manufacturing solutions.
What is the forecast market size for the US single-use bioreactors market by 2031?
The US single-use bioreactors market is forecast to reach $1,522.8 million by 2031, representing a 74.5% increase from the 2026 baseline.
RESEARCH METHODOLOGY
This research study relied extensively on secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global single-use bioreactors market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives at major market players, and industry consultants, to gather and validate critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with primary research inputs to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single-use bioreactors market. The secondary sources used for this study include National Institutes of Health (NIH), National Institute for Bioprocessing Research and Training (NIBRT), Society for Biological Engineering (SBE), Bio-Process Systems Alliance (BPSA), Biotechnology Innovation Organization (BIO), BioProcess International, BioPharm International, BioPlan Associates, Organisation for Economic Co-operation and Development (OECD) R&D Expenditure, National Center for Biotechnology Information (NCBI), World Health Organization (WHO), Food and Drug Administration (FDA); corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; and trade, business, and professional associations, among others. These sources were also used to obtain key information on major players, market classification and segmentation aligned with industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and to assess the market's future prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-use bioreactors market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed where applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Single-use bioreactors (SUBs) or disposable bioreactors consist of a disposable bag instead of a typical stainless steel or glass culture vessel. SUBs are based on single-use technology, which uses disposable components to manufacture biopharmaceutical products. The key benefits of single-use bioreactors include reduced risk of cross-contamination, lower capital and operational costs, faster turnaround times, and greater manufacturing flexibility. These advantages make single-use systems particularly attractive for producing biologics, vaccines, and personalized medicines, where flexibility, speed, and sterility are paramount.
The report presents the market size for single-use bioreactor systems, single-use bags, single-use assemblies, and other products that can be incorporated with single-use bioreactors.
Key Stakeholders
- Manufacturers of single-use bioreactors and associated products
- Distributors of single-use bioreactors and related products
- Pharmaceutical and biotechnology companies
- Contract manufacturing companies (CMOs)
- Contract research organizations (CROs)
- Academic and research institutes
- Life sciences companies
- Market research and consulting firms
- Venture capitalists and investors
- Government organizations
- Medical institutes and universities
- Private research firms
Report Objectives
- To define, describe, and forecast the global single-use bioreactors market based on product, type, cell type, process mode, molecule type, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall single-use bioreactors market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, and R&D activities in the single-use bioreactors market
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the single-use bioreactors market
Available customizations:
Based on the given market data, MarketsandMarkets offers customization to meet the company’s specific needs. The following customization options are available for this report:
Portfolio Assessment- Product Matrix, which gives a detailed comparison of the product portfolios of the top four companies.
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Geographical Analysis
- A further breakdown of the Rest of Europe single-use bioreactors market, by country
- A further breakdown of the Rest of Asia Pacific single-use bioreactors market, by country
- A further breakdown of the Rest of Latin America single-use bioreactors market, by country
Get the Full Single-Use Bioreactors Market Report
Full forecast, segment splits, and company analysis for all Single-Use Bioreactors Market.
- Canada Single-Use Bioreactors Market
- Germany Single-Use Bioreactors Market
- UK Single-Use Bioreactors Market
- France Single-Use Bioreactors Market
- Italy Single-Use Bioreactors Market
- Spain Single-Use Bioreactors Market
- China Single-Use Bioreactors Market
- South Korea Single-Use Bioreactors Market
- Japan Single-Use Bioreactors Market
- India Single-Use Bioreactors Market
- Australia Single-Use Bioreactors Market
- Brazil Single-Use Bioreactors Market
- Mexico Single-Use Bioreactors Market
- Rest Of Europe Single-Use Bioreactors Market
- Rest Of Asia Pacific Single-Use Bioreactors Market
- Rest Of Latin America Single-Use Bioreactors Market
- Rest Of GCC Countries Single-Use Bioreactors Market
- Saudi Arabia (Ksa) Single-Use Bioreactors Market
- United Arab Emirates (UAE) Single-Use Bioreactors Market
- GCC Countries Single-Use Bioreactors Market
- Rest Of Middle East Single-Use Bioreactors Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
